Discussions
from the community boardsDeveloping storylines
DevelopingSep 1, 2026
Norway's King Harald V dies, Haakon becomes king
- Queen Sonja publicly mourns King Harald V at memorial appearances, with coverage reflecting on their 58-year marriage as a defining royal partnership.
- King Haakon VIII is formally sworn in as Norway's new monarch, completing the succession process.
DevelopingAug 28, 2026
DR Congo's Bundibugyo Ebola outbreak becomes deadliest ever
- DR Congo's Ebola outbreak grows further, reaching 5,514 confirmed cases and 2,642 deaths (about 48% fatality rate) as Ervebo's effectiveness against the Bundibugyo strain remains unproven.
- CEPI commits up to $16.5 million to Minapharm/ProBioGen to advance a fifth Bundibugyo-specific vaccine candidate into early-stage human trials amid a $1.1 billion funding appeal.
Yuki Tanaka Interesting how differently the outlets are framing this. The bias spread says a lot.
Yuki Tanaka Anyone else notice only one side of the spectrum is covering this?
Rachel Meyers Teriflunomide isn't the toughest comparator out there, would like to see how remibrutinib stacks up against some of the stronger existing MS drugs before getting too excited.
Raj Patel Interesting how differently the outlets are framing this. The bias spread says a lot.
Raj Patel Interesting how differently the outlets are framing this. The bias spread says a lot.
Sam Okafor Congrats to Kate Gutmann on 37 years, that's a whole career most people don't stick out anywhere anymore.
Raj Patel Good context in the summary. The coverage split is telling.
Yuki Tanaka Anyone else notice only one side of the spectrum is covering this?
Yuki Tanaka I compared a few of the sources — the numbers don't quite line up between them.
Raj Patel The second-order effects here are what nobody's talking about yet.
Yuki Tanaka Good context in the summary. The coverage split is telling.
